Want to see FZMD full AI Analyst Report?
FZMD Stock Chart & Stats
$0.02
$0.02(33.27%)
At close: 4:00 PM EST
$0.02
$0.02(33.27%)
Day’s Range― - ―
52-Week Range$0.02 - $0.10
Previous CloseN/A
Volume1.00K
Average Volume (3M)354.00
Market Cap
$1.70M
Enterprise Value$3.49M
Total Cash (Recent Filing)$253.38K
Total Debt (Recent Filing)$2.22M
Price to Earnings (P/E)10.0
Beta-1.41
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding73,895,800
10 Day Avg. Volume988
30 Day Avg. Volume354
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)0.21
Price to Sales (P/S)0.16
P/FCF Ratio10.24
Enterprise Value/Market Cap2.05
Enterprise Value/Revenue0.19
Enterprise Value/Gross Profit0.29
Enterprise Value/Ebitda0.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Operational ImprovementsPositive EBIT and EBITDA margins indicate operational improvements, suggesting the company is managing its core operations more efficiently, which could lead to better profitability in the long term.
Gross Profit MarginA stable Gross Profit Margin of 64% reflects strong pricing power and cost management, which can provide a buffer against revenue volatility and support long-term financial health.
Improved Equity RatioAn improved Equity Ratio suggests a stronger asset structure, enhancing the company's financial stability and reducing reliance on debt, which is crucial for long-term sustainability.
Bears Say
Declining RevenueThe significant decline in revenue over recent years indicates challenges in market demand or competitive positioning, which could hinder growth prospects and financial recovery.
High LeverageHigh leverage poses a risk to financial flexibility, increasing vulnerability to economic downturns and limiting the company's ability to invest in growth opportunities.
Negative Cash FlowConsistent negative Free Cash Flow indicates ongoing liquidity challenges, which can restrict operational capabilities and strategic investments, impacting long-term viability.
FZMD FAQ
What was Fuse Medical Inc’s price range in the past 12 months?
Fuse Medical Inc lowest stock price was $0.02 and its highest was $0.10 in the past 12 months.
What is Fuse Medical Inc’s market cap?
Fuse Medical Inc’s market cap is $1.70M.
When is Fuse Medical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Fuse Medical Inc’s earnings last quarter?
Currently, no data Available
Is Fuse Medical Inc overvalued?
According to Wall Street analysts Fuse Medical Inc’s price is currently Overvalued.
Does Fuse Medical Inc pay dividends?
Fuse Medical Inc pays a Notavailable dividend of $7.353 which represents an annual dividend yield of N/A. See more information on Fuse Medical Inc dividends here
What is Fuse Medical Inc’s EPS estimate?
Fuse Medical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fuse Medical Inc have?
Fuse Medical Inc has 73,895,800 shares outstanding.
What happened to Fuse Medical Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Fuse Medical Inc?
Currently, no hedge funds are holding shares in FZMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fuse Medical Inc
Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based manufacturer and supplier of medical device implants. Its product portfolio primarily encompasses a wide range of orthopedic implants. This includes specialized internal and external fixation devices for the foot and ankle, as well as plating systems and total joint reconstruction implants designed for upper and lower extremities. Additionally, Fuse Medical provides solutions for soft tissue fixation and augmentation, catering to sports medicine procedures. The company's offerings extend to comprehensive spinal implants, addressing indications such as trauma, degenerative disc disease, and various deformities. Beyond its orthopedic line, the company also supplies osteo-biologics and regenerative products. These encompass a variety of materials such as human allografts, tendons, synthetic skin, bone substitutes, and other regenerative tissues. Fuse Medical's client base includes hospitals, diverse medical facilities, and a network of sub-distributors.